Ligand · K25
K25 · 4,5,6,7-tetrabromo-N,N-dimethyl-1H-benzimidazol-2-amine
K25, 4,5,6,7-tetrabromo-N,N-dimethyl-1H-benzimidazol-2-amine (C9 H7 Br4 N3, 476.8 g/mol), in the MolNFT structures on GenesisL1: bound in 6 records (3 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds…
- Component
- K25
- Formula
- C9 H7 Br4 N3
- Class
- ligand
- Structures
- 6
- PDB entries
- 3
Binding sites
K25 in 6 structures; the first of them:
- 1ZOE · Crystal structure of protein kinase CK2 in complex with TBB-derivatives inhibitors · K25 A501 · binds VAL45, GLY46, ARG47, SER51, VAL53, ILE66, LYS68, VAL95 and 7 more
- 4U7F · Reduced qui reductase 2 in complex with CK2 inhibitor DMAT · K25 B301 · binds TRP105, GLY149, GLY150, GLU193, GLY68, THR71, GLN122, PHE126 and 1 more
- 4U7H · Oxidized qui reductase 2 in complex with CK2 inhibitor DMAT · K25 B301 · binds TRP105, PHE106, GLY149, GLY150, MET154, TYR155, ASN161, GLN122 and 4 more
- 1ZOE · Crystal structure of protein kinase CK2 in complex with tbb- derivatives inhibitors · K25 A501 · binds VAL45, GLY46, ARG47, SER51, VAL53, ILE66, LYS68, VAL95 and 7 more
- 4U7F · Reduced quinone reductase 2 in complex with CK2 inhibitor dmat · K25 B301 · binds TRP105, GLY149, GLY150, GLU193, GLY68, THR71, GLN122, PHE126 and 1 more
- 4U7H · Oxidized quinone reductase 2 in complex with CK2 inhibitor dmat · K25 B301 · binds TRP105, PHE106, GLY149, GLY150, MET154, TYR155, ASN161, GLN122 and 4 more
Residues it binds most
GLY 10, PHE 10, GLN 8, GLU 8, TRP 8, TYR 4, VAL 2, ASN 6, ILE 2, MET 4 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.